Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70051 - 70075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CRY2	1408	upregulated	Silicon Dioxide results in increased expression of CRY2 mRNA	11p11.2	A24196
Silicon dioxide	Approved	CRYAB	1410	downregulated	Silicon Dioxide analog results in decreased expression of CRYAB mRNA	11q23.1	A24194
Silicon dioxide	Approved	CRYAB	1410	upregulated	Silicon Dioxide analog results in increased expression of CRYAB mRNA	11q23.1	A24195
Silicon dioxide	Approved	CRYAB	1410	upregulated	Silicon Dioxide results in increased expression of CRYAB mRNA	11q23.1	A24197 A24196
Silicon dioxide	Approved	CRYBA1	1411	upregulated	Silicon Dioxide analog results in increased expression of CRYBA1 mRNA	17q11.2	A24194
Silicon dioxide	Approved	CRYBB2	1415	upregulated	Silicon Dioxide analog results in increased expression of CRYBB2 mRNA	22q11.23	A24195
Silicon dioxide	Approved	CRYBB2P1	1416	downregulated	Silicon Dioxide results in decreased expression of CRYBB2P1 mRNA	22q11.2-q12.1	A24196
Silicon dioxide	Approved	CRYBB3	1417	upregulated	Silicon Dioxide analog results in increased expression of CRYBB3 mRNA	22q11.23	A24195
Silicon dioxide	Approved	CRYL1	51084	downregulated	Silicon Dioxide analog results in decreased expression of CRYL1 mRNA	13q12.11	A24195
Silicon dioxide	Approved	CRYM	1428	downregulated	Silicon Dioxide analog results in decreased expression of CRYM mRNA	16p12.2	A24195
Silicon dioxide	Approved	CRYM	1428	upregulated	Silicon Dioxide results in increased expression of CRYM mRNA	16p12.2	A24197 A24196
Silicon dioxide	Approved	CSF1	1435	upregulated	Silicon Dioxide results in increased expression of CSF1 mRNA	1p13.3	A24196
Silicon dioxide	Approved	CSF2	1437	upregulated	Silicon Dioxide analog results in increased expression of CSF2 mRNA	5q31.1	A24194 A24195
Silicon dioxide	Approved	CSF2	1437	upregulated	Silicon Dioxide results in increased expression of CSF2 mRNA	5q31.1	A24200 A24197 A24205 A24196
Silicon dioxide	Approved	CSF2RA	1438	upregulated	Silicon Dioxide analog results in increased expression of CSF2RA mRNA	Xp22.32 and Yp11.3	A24195
Silicon dioxide	Approved	CSF3	1440	upregulated	Silicon Dioxide analog results in increased expression of CSF3 mRNA	17q21.1	A24194 A24195
Silicon dioxide	Approved	CSGALNACT1	55790	upregulated	Silicon Dioxide analog results in increased expression of CSGALNACT1 mRNA	8p21.3	A24194
Silicon dioxide	Approved	CSGALNACT2	55454	upregulated	Silicon Dioxide analog results in increased expression of CSGALNACT2 mRNA	10q11.21	A24194 A24195
Silicon dioxide	Approved	CSHL1	1444	downregulated	Silicon Dioxide analog results in decreased expression of CSHL1 mRNA	17q23.3	A24195
Silicon dioxide	Approved	CSRNP1	64651	upregulated	Silicon Dioxide analog results in increased expression of CSRNP1 mRNA	3p22.2	A24194
Silicon dioxide	Approved	CSRP1	1465	upregulated	Silicon Dioxide analog results in increased expression of CSRP1 mRNA	1q32.1	A24195
Silicon dioxide	Approved	CSRP2	1466	upregulated	Silicon Dioxide results in increased expression of CSRP2 mRNA	12q21.2	A24196
Silicon dioxide	Approved	CST1	1469	downregulated	Silicon Dioxide analog results in decreased expression of CST1 mRNA	20p11.21	A24195
Silicon dioxide	Approved	CST2	1470	downregulated	Silicon Dioxide analog results in decreased expression of CST2 mRNA	20p11.21	A24195
Silicon dioxide	Approved	CSTA	1475	downregulated	Silicon Dioxide analog results in decreased expression of CSTA mRNA	3q21.1	A24195

Displaying entries 70051 - 70075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability